HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shao H Yang Selected Research

p21(ras) farnesyl-protein transferase (protein farnesyltransferase)

2/2013Targeting protein prenylation in progeria.
4/2010Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer.
2/2010Assessing the efficacy of protein farnesyltransferase inhibitors in mouse models of progeria.
10/2006Protein farnesyltransferase inhibitors and progeria.
3/2006A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria.
7/2005Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shao H Yang Research Topics

Disease

21Progeria (Hutchinson Gilford Syndrome)
04/2016 - 12/2004
2Inborn Genetic Diseases (Disease, Hereditary)
05/2015 - 09/2011
2Cardiomyopathies (Cardiomyopathy)
02/2013 - 01/2011
2Carcinogenesis
04/2010 - 01/2008
1Esophageal Achalasia (Megaesophagus)
05/2015
1Ichthyosis (Xeroderma)
12/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2014
1Lipodystrophy
02/2013
1Demyelinating Diseases (Demyelinating Disease)
02/2013
1Muscular Dystrophies (Muscular Dystrophy)
02/2013
1Peripheral Nervous System Diseases (PNS Diseases)
02/2013
1Leukoencephalopathies
02/2013
1Hyperbilirubinemia
01/2012
1Blister (Bulla)
07/2010
1Neoplasm Metastasis (Metastasis)
04/2010
1Lung Neoplasms (Lung Cancer)
04/2010
1Neoplasms (Cancer)
04/2010
1Premature Aging
10/2008
1Rare Diseases (Rare Disease)
10/2008
1Muscle Weakness
03/2006
1Osteoporosis
12/2004
1Alopecia (Baldness)
12/2004
1Micrognathism
12/2004

Drug/Important Bio-Agent (IBA)

20prelamin AIBA
04/2016 - 12/2004
7Lamin Type A (Lamin A)IBA
01/2011 - 12/2004
6p21(ras) farnesyl-protein transferase (protein farnesyltransferase)IBA
02/2013 - 07/2005
5lamin CIBA
04/2016 - 07/2005
3LaminsIBA
12/2014 - 09/2011
2geranylgeranyltransferase type-I (protein geranylgeranyltransferase)IBA
01/2012 - 04/2010
2Proteins (Proteins, Gene)FDA Link
04/2010 - 01/2008
2LipidsIBA
04/2010 - 01/2009
2Farnesyltranstransferase (Farnesyltransferase)IBA
01/2008 - 08/2006
1ChromatinIBA
12/2014
1lonafarnib (SCH 66336)IBA
02/2013
1Lamin Type B (Lamin B)IBA
02/2013
1Transaminases (Aminotransferases)IBA
01/2012
1RNA Splice SitesIBA
07/2009
1Antisense OligonucleotidesIBA
07/2009
1Protein Isoforms (Isoforms)IBA
01/2008
1glycylpeptide N-tetradecanoyltransferaseIBA
01/2008
1EnzymesIBA
03/2006

Therapy/Procedure

1Therapeutics
04/2010